soul trial oral semaglutide cardiovascular outcomes soul trial results of and tirzepatide for patients with type 2 diabetes in clinical practice Cardio-kidney-metabolic protective effects of semaglutide

Quick Answer: Semaglutide is not directly associated with heart palpitations as a common adverse reaction, though it can increase resting heart rate by 1-4 beats per minute, which some patients may perceive as palpitations

GLP-1: The Incretin Hormone GLP-1 is an essential hormone released during the digestion process to help regulate blood sugar levels

Take Certain Medications Some medications can interact with semaglutide, potentially altering its effectiveness and duration of action or causing increased side effects

March 8th, 2025: Vision Loss Allegations Lead Users to Pursue Legal Action Lawsuits continue to grow against the makers of GLP-1 medications like Ozempic, Mounjaro, and Wegovy, as patients report unexpected and irreversible vision problems

August 2010